PMV Pharmaceuticals, Inc. PMVP
1.38 USD +0.01 (+0.73%)
At closeNov 3, 2026, 4:00 PM EST
1.38 0.00 0.00%
After hours · Nov 3, 4:00 PM ET
1.33 Day range 1.42
1.02 52-week range 1.91
- YTD
- +10.40%
- 1 year
- -1.43%
Analyst view
Price target (mean) 5.80 +320.3% upside
Now 1.38
- Target (low)
- 5.00
- Target (mean)
- 5.80
- Target (high)
- 7.00
Ratings (0m) 6 6 buy · 0 hold · 0 sell
- Strong buy1
- Buy5
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 6
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.3825 | -0.41 – -0.36 | -0.31 | -23.4% | 0 | 0.0% | 4 |
| Next quarter | -0.39 | -0.43 – -0.37 | -0.30 | -30.0% | 0 | 0.0% | 3 |
| Current year | -1.08 | -1.10 – -1.05 | -1.44 | +25.0% | 0 | 0.0% | 3 |
| Next year | -1.67 | -1.78 – -1.57 | -1.08 | -54.6% | 0 | 0.0% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 20, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 30, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 13, 2024 | Craig-Hallum | Initiated | — | Buy |
| Apr 12, 2024 | Jefferies | Initiated | — | Buy |
| Mar 7, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Dec 27, 2023 | Ladenburg Thalmann | Initiated | — | Buy |
| Oct 16, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 11, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 17, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 11, 2023 | Oppenheimer | Reiterated | Outperform | Outperform |
| Mar 20, 2023 | HC Wainwright & Co. | Maintained | — | Buy |
| Mar 2, 2023 | Oppenheimer | Maintained | — | Outperform |
| Nov 17, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Jun 9, 2022 | Oppenheimer | Maintained | — | Outperform |
| May 24, 2022 | Goldman Sachs | Maintained | — | Buy |
| Mar 2, 2022 | Oppenheimer | Upgrade | Perform | Outperform |
| Sep 22, 2021 | Goldman Sachs | Upgrade | Neutral | Buy |
| Aug 19, 2021 | Oppenheimer | Initiated | — | Perform |
| Aug 2, 2021 | Guggenheim | Initiated | — | Buy |
| Jul 29, 2021 | HC Wainwright & Co. | Initiated | — | Buy |
| Oct 20, 2020 | Cowen & Co. | Initiated | — | Outperform |
| Oct 20, 2020 | B of A Securities | Initiated | — | Buy |
| Oct 20, 2020 | Goldman Sachs | Initiated | — | Neutral |